Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
News

American Stores Pull Formula Off Their Shelves

In a small reminder that the fate of American Jews is never far removed from that of Israelis, the panic over a defective Remedia baby formula quickly spread to the Orthodox enclaves of New York, where some Remedia products are sold in stores.

There have been no reported cases of sickness in America so far, but New York City’s Department of Health and Mental Hygiene sent a health alert to physicians throughout the city and a news release bearing a photograph of a Remedia can.

On Saturday, synagogues made announcements in services, and in the Flatbush and Borough Park sections of Brooklyn, the Hatzolah Volunteer Ambulance Corps dispatched its drivers through the streets to warn parents by loudspeaker about the defective formula.

Because it was a life-or-death matter, the prohibition against driving did not apply, explained Hatzolah’s president, Heshey Jacob.

Pittsburgh-based H.J. Heinz Co., which is a principal owner of Remedia, released a statement that said: “The Remedia formula is not manufactured, sold, or marketed anywhere else in the world besides Israel. The product is not exported for sale in the U.S., but it is possible that some independent companies have shipped very small amounts to here or other countries, generally for consumption by families who follow kosher dietary laws.”

A number of stores in Brooklyn were selling Remedia formula, all of which quickly removed the product from shelves.

Daniel Botnick, executive director of the Crown Heights Jewish Community Council, said it has been difficult to find any information on the Remedia formula that made its way to the United States.

“My daughter has used the formula with her baby,” Botnick said. “When she called the Food and Drug Administration to learn what she should do, they told her to call back tomorrow. It’s been very frustrating.”

While Heinz provided an American telephone number for journalists, the press release told concerned parents to call a special number in Israel.

The Crown Heights Community Council blew up the letter from Heinz and displayed it in their window, with the only definite information that has been given so far: “Parents of children who may be using Remedia soy-based formula are advised to contact their doctor.”

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version